Varda's Delian Asparouhov: winning low Earth orbit is a strategic imperative

In a June 2026 Free Press feature timed to SpaceXDealroom has a profile for this one. Try Dealroom →'s IPO registration — expected to be the largest in history at a ~$1.75 trillion valuation — Varda Space Industries co-founder Delian Asparouhov framed in-space manufacturing as a question of national strategy, not just commercial opportunity.

"Whoever nails economic activity in low Earth orbit by default basically wins the rest of the solar system and likely the rest of the galaxy," Asparouhov said. "I think it's incredibly important that a Western democratic free nation does that first."

The argument: SpaceX's collapse in launch costs and rise in launch frequency has made orbital data centres, manufacturing hubs, and labs commercially viable for the first time — the foundation on which Varda is building. Asparouhov, a partner at Founders Fund and founder of the Hill & Valley Forum, has pursued a vision of industrialising space — in-orbit manufacturing, asteroid mining, lunar ice and helium-3 extraction — since middle school.

Varda manufactures pharmaceuticals in the microgravity of low Earth orbit and returns them to Earth in autonomous reentry capsules, with the strategic case for orbital industrial capacity sitting alongside its commercial pharma thesis.

Read more: The Free Press · Delian Asparouhov on X